Dr. Michael Nicolo Ferrandino, MD

Dr. Ferrandino practices at Colorado Urology in Aurora, Colorado.

Dr. Ferrandino's NPI, 1962611905, was assigned on May 22, 2007. Dr. Ferrandino graduated from New York University School of Medicine in 2001. Dr. Ferrandino's North Carolina license number on file is 2007-00807.

Dr. Ferrandino's primary practice is Colorado Urology, at 1411 S Potomac St, Aurora, CO 80012 in Arapahoe County. The practice phone is (303) 695-6106.

Dr. Ferrandino's primary practice is Colorado Urology in Aurora, Colorado. Dr. Ferrandino is also affiliated with Foothills Hospital. The medical group on file is Colorado Urology. Dmand AI also links Dr. Ferrandino to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferrandino practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ferrandino's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ferrandino is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ferrandino's licenses on file in 3 states: North Carolina, Colorado and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer and prostate surgery among the conditions Dr. Ferrandino treats.

CMS data shows 2,014 Medicare services from Dr. Ferrandino across 21 procedure codes in 2024, for 456 Medicare patients. Medicare paid $97,643 for them.

CMS counts 456 Medicare patients who saw Dr. Ferrandino in 2024. The largest group is 65 to 74, with 237 patients. 71% of them have high cholesterol, and 69% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ferrandino's median patient age at 69, with 19% women.

In 2024, Dr. Ferrandino wrote 1,329 Medicare Part D claims for 379 patients. 76% of them were for generic drugs. CMS names the drug for 1,208 of them, across 22 drugs with 11 or more claims each, at $368,703 in total drug cost. In 2023, CMS named 739 claims across 17 drugs.

Dr. Ferrandino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ferrandino as offering telehealth. CMS counts 17 procedures of prostate resection by Dr. Ferrandino, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 49 papers to Dr. Ferrandino, published from 2008 to 2024. 2012 was the busiest year, with 7. The most frequent topics are Nephrostomy, Percutaneous, Radiation Dosage and Kidney Calculi. Dr. Ferrandino has published most often in J Endourol. Dr. Ferrandino's most frequent co-authors are Agnes J. Wang, MD, Giao Chau Nguyen, MD and Fernando J. Cabrera, MD.

CMS Open Payments shows 218 general payments to Dr. Ferrandino from 44 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Arrow International, Inc. paid the most, $6,156.

Dmand AI lists 1 award for Dr. Ferrandino, most recently CMS Stage 1 EHR in 2013.

Dr. Ferrandino graduated from New York University School of Medicine in 2001.

Dr. Ferrandino is in network with 19 carriers, including Aetna, Cigna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.